Dissociative disorders sit at the intersection of trauma, identity, and consciousness, and they are routinely missed in general psychiatric and emergency settings because clinicians underestimate prevalence and overestimate how dramatic the presentation will be. DSM-5-TR groups three principal entities under chapter heading Dissociative Disorders: dissociative identity disorder (DID), dissociative amnesia (with or without dissociative fugue), and depersonalization/derealization disorder (DPDR), alongside the residual categories other specified and unspecified dissociative disorder. Most patients with chronic dissociative pathology have a developmental trauma history, present polysymptomatically (mood, anxiety, PTSD, self-harm), and have spent years carrying a different diagnostic label before dissociation is recognized. The dominant treatment paradigm is phase-oriented psychotherapy — safety and stabilization, then trauma processing, then integration — with pharmacotherapy targeting comorbid conditions rather than dissociation itself. The bottom line for the resident: screen for dissociation in any treatment-resistant mood, anxiety, or post-traumatic presentation, distinguish it carefully from psychosis and seizure, and resist the urge to medicate the dissociative symptoms directly.

Dissociative disorders are more prevalent than historical caricature suggests, but the numbers vary widely by setting, instrument, and population, with community estimates, inpatient cohorts, and forensic samples disagreeing by an order of magnitude. The signal across studies is that dissociative pathology is common in trauma-exposed psychiatric populations and routinely under-recognized.

Prevalence

• 12-month prevalence of Dissociative identity disorder in U.S. community samples is approximately 1.5%, with comparable rates reported in clinical and inpatient settings.^1-2
• Lifetime prevalence of Dissociative amnesia is reported around 1.8% in community studies, though acute presentations are concentrated in war zones, disaster settings, and high-trauma clinical samples.^1,3
• Depersonalization/derealization disorder has an estimated lifetime prevalence near 2%, while transient depersonalization or derealization symptoms occur in roughly half of the general population at least once.^1,4
• Inpatient psychiatric samples show DID prevalence between 1% and 5%, with even higher rates in specialty trauma units.^2,5

Demographics

• Female-to-male ratio in clinical samples of DID is approximately 9:1, attributed in part to differential help-seeking and trauma exposure patterns rather than true biologic predominance.^2,5
• DPDR onset is typically in adolescence or early adulthood, with mean age of onset around 16 years.⁴
• Dissociative amnesia can occur at any age but most often follows acute psychological trauma or chronic interpersonal violence.³

Comorbidity

• More than 90% of patients with DID meet criteria for at least one comorbid condition, most commonly Posttraumatic stress disorder, major depressive disorder, borderline personality disorder, and substance use disorders.^2,6
• Lifetime rates of suicide attempts in DID exceed 70% in clinical samples, with non-suicidal self-injury reported in over half.^2,6
• DPDR shows high comorbidity with anxiety disorders and depression but, unlike DID, weaker association with overt personality pathology.⁴

Risk factors

• Childhood maltreatment — particularly chronic physical and sexual abuse before age 9 — is the most consistently replicated risk factor for chronic dissociative disorders.^2,5-6
• Other contributors include emotional neglect, disorganized attachment, repeated medical trauma, and combat or refugee experience.^5-6
• For DPDR specifically, panic attacks, cannabis and hallucinogen use, and severe sleep deprivation can precipitate index episodes.⁴

Dissociation is best understood as a failure of integration of consciousness, memory, identity, perception, and motor control, with developmental trauma as the principal but not exclusive driver. Mechanistic work has shifted from purely psychodynamic models toward circuit-level accounts that overlap with PTSD neurobiology.

Neurobiology

• Functional imaging in DID and the dissociative subtype of PTSD shows increased medial prefrontal and anterior cingulate activity with reciprocal limbic (amygdala, insula) hypoactivation during dissociative states, a pattern often described as cortico-limbic over-modulation.^6-7
• Structural studies report reduced hippocampal and amygdalar volumes in DID, paralleling findings in chronic PTSD.^6-7
• DPDR is associated with hypoactivation of the insula and emotion-related limbic regions and altered Default mode network connectivity, consistent with the clinical phenomenology of blunted emotional experience without classical anxiety arousal.^4,7
• Pharmacologic probes implicate glutamatergic (NMDA), opioid, and cannabinoid systems: ketamine reliably produces depersonalization, and naloxone reduces DPDR symptoms in small trials.^4,8

Genetics and heritability

• Twin studies estimate heritability of dissociative experiences at roughly 50%, comparable to other trauma-related phenotypes, with the remainder attributable to non-shared environmental factors.⁷
• No replicated single-locus association has emerged; candidate gene work has implicated FKBP5 and other stress-axis regulators, mirroring PTSD genetics.⁷

Environmental factors

• Early, chronic, interpersonal trauma during sensitive periods of identity development is the most strongly supported environmental contributor to DID.^2,5-6
• Acute, overwhelming trauma — combat, assault, disaster — more typically precipitates dissociative amnesia or acute dissociative reactions.^3,5
• Substances, sleep deprivation, and panic can trigger DPDR episodes in vulnerable individuals.⁴

Integrative models

• The trauma model (Putnam, Spiegel, ISSTD) frames DID as a developmental outcome in which dissociation, adaptive in early childhood, becomes maladaptive when self-states fail to integrate.^5-6
• The sociocognitive or fantasy model (Lynn, Lilienfeld) argues that DID is largely iatrogenic or shaped by sociocultural expectations; current weight of evidence — including imaging, treatment-response, and prospective data — favors the trauma model, while acknowledging that suggestive techniques can shape presentation.^6,9
• Both camps agree that suggestive or leading interview techniques can distort memory and presentation and should be avoided.^6,9

DSM-5-TR groups dissociative identity disorder, dissociative amnesia, and depersonalization/derealization disorder as the three principal entities, with other specified and unspecified dissociative disorder for clinically significant presentations that do not fit a defined category. The criteria emphasize disruption of integration across consciousness, memory, identity, emotion, perception, body representation, and behavior, and require clinically significant distress or impairment.¹

Dissociative identity disorder

• Disruption of identity characterized by two or more distinct personality states, which may be described in some cultures as an experience of possession; the disruption involves marked discontinuity in sense of self and agency with related alterations in affect, behavior, consciousness, memory, perception, cognition, or sensorimotor functioning.¹
• Recurrent gaps in recall of everyday events, important personal information, or traumatic events that are inconsistent with ordinary forgetting.¹
• Symptoms cause clinically significant distress or functional impairment, are not a normal part of a broadly accepted cultural or religious practice, and are not attributable to substances or another medical condition; in children, symptoms are not better explained by imaginary playmates or fantasy play.¹

Dissociative amnesia

• Inability to recall important autobiographical information, usually of a traumatic or stressful nature, that is inconsistent with ordinary forgetting.¹
• Symptoms cause clinically significant distress or functional impairment and are not attributable to substances, a neurologic or other medical condition, or another mental disorder.¹
• Specifier: with dissociative fugue — apparently purposeful travel or bewildered wandering associated with amnesia for identity or other autobiographical information.¹
• Amnesia patterns: localized (specific period), selective (some events of a period), generalized (entire life history), systematized (specific category of information), or continuous (each new event as it occurs).¹

Depersonalization/derealization disorder

• Persistent or recurrent experiences of depersonalization (detachment from one's thoughts, feelings, body, or actions, often with an as-if quality) or derealization (detachment from surroundings, which feel unreal, dreamlike, foggy, or visually distorted).¹
• Reality testing remains intact during the experiences — the patient knows the unreal quality is internal — which distinguishes the disorder from psychosis.^1,4
• Symptoms cause clinically significant distress or impairment and are not attributable to substances, another medical condition, or another mental disorder including panic disorder, PTSD, or schizophrenia spectrum.¹

Other specified and unspecified dissociative disorder

• Other specified dissociative disorder captures clinically significant presentations that do not meet full criteria, including chronic mixed dissociative symptoms not meeting DID criteria, identity disturbance from prolonged coercive persuasion, acute dissociative reactions to stressful events, and dissociative trance.¹
• Unspecified dissociative disorder is used when the clinician chooses not to specify, including emergency-department presentations with insufficient information.¹

ICD-11 differences

• ICD-11 reorganized dissociative disorders under chapter 06 and distinguishes dissociative neurologic symptom disorder (corresponding broadly to DSM-5-TR functional neurological symptom disorder) from the identity, amnesia, and depersonalization-derealization entities.¹⁰
• ICD-11 introduces partial dissociative identity disorder for presentations with non-dominant personality states that intrude on functioning without recurrent executive control, a category with no direct DSM-5-TR equivalent.¹⁰
• Trance disorder and possession trance disorder are separately defined in ICD-11 with explicit cultural-context criteria.¹⁰

Patients with dissociative disorders rarely present with the dramatic, theatrical switching depicted in popular media; far more commonly, the picture is a chronic, polysymptomatic course with prominent mood, anxiety, post-traumatic, and somatic complaints, and dissociation must be actively sought.

Symptom clusters

• Amnesia for autobiographical information, everyday events, or learned skills, often noticed by collateral informants before the patient.^2,6
• Identity alteration ranging from subtle self-state shifts to overt switching between named alternate identities with distinct memory, affect, and behavior.^2,6
• Depersonalization and derealization phenomena including out-of-body experiences, emotional numbing, perceptual distortions, and the as-if quality of self and world.⁴
• Schneiderian first-rank symptoms — particularly audible thoughts, voices arguing or commenting, and made actions — occur in DID and historically led to misdiagnosis as schizophrenia.^2,6
• Somatoform features including non-epileptic seizures, conversion symptoms, and unexplained pain are common, especially in DID.^2,6

Prodrome and course

• DID typically becomes clinically apparent in the third to fourth decade, often after a precipitating life event, despite originating in childhood; the average patient spends 5-12 years in mental-health treatment before correct diagnosis.^2,6
• DPDR may begin abruptly, often after a panic attack, cannabis use, or psychological stressor, and frequently follows a chronic, fluctuating course.⁴
• Dissociative amnesia ranges from a single acute episode with full recovery to chronic, generalized forms that may persist for years.^3,5

Atypical presentations and red flags

• Apparent treatment-resistant depression, PTSD, or borderline personality disorder, particularly with self-injury, suicidality, and recurrent hospitalizations, should prompt active screening for dissociation.^2,6
• Patients describing internal voices that they recognize as their own thoughts (ego-syntonic, identified as parts of self) rather than external persecutors are more likely dissociative than psychotic.^2,6
• Time loss, finding unfamiliar items, being addressed by unfamiliar names, and inconsistent skills or handwriting are corroborating features.^2,6
• DANGER: Do not diagnose DID on the basis of media-influenced expectations or after suggestive interviewing; iatrogenic shaping of self-states is a recognized clinical hazard.^6,9

The differential for dissociation is broad and crosses into neurology, general medicine, and forensic psychiatry. The clinician's task is to distinguish dissociative pathology from medical and neurologic conditions that can mimic it, from other psychiatric disorders with overlapping phenomenology, and from feigned or factitious presentations.

Psychiatric differentials

• PTSD, particularly the dissociative subtype, overlaps substantially with DID but lacks the recurrent identity discontinuity and pervasive amnesia for everyday events.^1,6
• Schizophrenia spectrum disorders can be confused with DID because of Schneiderian symptoms, but dissociative voices are typically experienced as internal and ego-syntonic, reality testing is preserved, and negative symptoms are uncommon.^2,6
• Borderline personality disorder shares identity disturbance, self-harm, and affective instability, but identity diffusion in BPD is continuous rather than alternating discrete self-states.^2,6
• Bipolar disorder, particularly with rapid mood shifts, can mimic switching; mood-congruent psychomotor and sleep changes and a chronologic pattern point to bipolarity.^1-2
• Panic disorder with depersonalization is distinguished from DPDR by the dominance of autonomic anxiety symptoms and the time-limited nature of dissociation during attacks.^1,4
• Factitious disorder and malingering must be considered, especially in forensic contexts; structured instruments and longitudinal observation are more reliable than single-interview judgments.^6,9

Medical and neurologic mimics

• Temporal lobe epilepsy and other focal seizures can produce depersonalization, déjà vu, amnesia, and complex automatisms; EEG and ictal video monitoring resolve most cases.^3-4
• Transient global amnesia presents with acute, isolated anterograde amnesia lasting hours, typically in older adults, without identity disturbance.³
• Traumatic brain injury, encephalitis (including autoimmune limbic encephalitis), CNS neoplasm, and stroke can produce amnesia or depersonalization.^3-4
• Migraine aura and vestibular disorders may cause derealization-like phenomena.⁴
• Endocrine and metabolic disturbances — thyroid disease, hypoglycemia, hyponatremia, hypercortisolism — and B12 deficiency can present with cognitive and dissociative-like symptoms.³
• Substance intoxication and withdrawal, particularly with cannabis, hallucinogens, ketamine, dissociative anesthetics, and alcohol, commonly produce depersonalization and amnesia.⁴

Assessment is built on an unhurried, non-leading clinical interview supported by validated screening and structured instruments and a targeted medical workup. The order matters: rule out medical and substance causes, screen broadly for dissociation when the clinical picture warrants, and corroborate with collateral information when possible.

Interview approach

• Use open-ended, non-leading questions; avoid hypnotic, suggestive, or leading techniques that can shape memory or self-state presentation.^6,9
• Inquire systematically about time loss, finding unfamiliar belongings, unrecognized handwriting, being called by unfamiliar names, and gaps in autobiographical memory.^2,6
• Screen for trauma history with sensitivity to retraumatization; defer detailed trauma narrative until stabilization.⁶
• Obtain collateral history from family or longstanding contacts when consent permits, particularly for amnesia and identity-alteration claims.^2,6

History elements

• Developmental trauma history, attachment context, and prior dissociative symptoms in childhood.^5-6
• Detailed substance-use history including cannabis, hallucinogens, dissociative anesthetics, and prescribed medications with dissociative effects.⁴
• Sleep, head-injury, and seizure history.^3-4
• Prior psychiatric diagnoses, treatment response, and hospitalizations, with attention to repeated misdiagnosis patterns.^2,6

Physical and neurologic exam

• Full neurologic examination is mandatory in new-onset amnesia or depersonalization, including cognitive screening with the Montreal Cognitive Assessment when indicated.^3-4
• Look for evidence of self-injury, somatoform symptoms, and conversion findings.^2,6

Rating scales and structured interviews

• Dissociative Experiences Scale (DES-II): 28-item self-report screen; a mean score ≥30 raises suspicion for a dissociative disorder, though it is not diagnostic.^6,11
• Structured Clinical Interview for DSM-5 Dissociative Disorders (SCID-D): the reference-standard semi-structured diagnostic interview.^6,11
• Multidimensional Inventory of Dissociation (MID): 218-item self-report measure with detailed symptom profiling for treatment planning.^6,11
• Cambridge Depersonalization Scale: 29-item measure specific to DPDR symptom severity.⁴
• Screen for comorbid PTSD with the Clinician-Administered PTSD Scale (CAPS-5) or PCL-5.⁶

Laboratory and imaging

• Baseline labs for new presentations: CBC, comprehensive metabolic panel, TSH, B12, urine toxicology, and HIV when risk factors are present.^3-4
• EEG when seizure mimics are plausible; MRI brain when focal neurologic signs, atypical age of onset, or treatment-resistant presentation raise concern for structural lesion.^3-4
• Targeted autoimmune and infectious workup (e.g., NMDA-receptor antibodies, syphilis serology) when subacute neuropsychiatric onset suggests encephalitis.³

What not to order

• Routine brain imaging in a clinically clear, longstanding dissociative presentation without focal signs has low yield.^3-4
• Sodium amytal ("truth serum") interviews and hypnotically refreshed memory have no place in contemporary diagnostic practice and risk producing confabulated material.^6,9

Phase-oriented psychotherapy is the cornerstone of treatment across the dissociative disorders, with pharmacotherapy targeting comorbid conditions rather than dissociation itself. The evidence base is dominated by case series, open trials, and expert consensus; few randomized trials exist and most are small. Apply the GRADE wording table conservatively.

Pharmacotherapy

• No medication is FDA-approved for any dissociative disorder; pharmacologic treatment targets comorbid depression, anxiety, PTSD, and sleep disturbance.^6,11
• SSRIs and SNRIs are commonly recommended for comorbid depression, anxiety, and PTSD symptoms, with the same first-line considerations that apply outside the dissociative context.^6,11
• Limited evidence suggests that prazosin may reduce trauma-related nightmares in comorbid PTSD with dissociative features.^6,11
• For DPDR specifically, small open trials and case series suggest possible benefit from SSRIs combined with lamotrigine or with naltrexone, but high-quality evidence is lacking.^4,8
• Some experts recommend low-dose naltrexone for depersonalization, though high-quality evidence is lacking.^4,8
• Benzodiazepines can transiently relieve anxiety but worsen dissociation, impair trauma processing, and carry dependence risk; routine use is discouraged.^6,11
• Antipsychotics are not effective for primary dissociative symptoms and risk reinforcing misdiagnosis when used for ego-syntonic dissociative voices.^6,11

Psychotherapy

• International Society for the Study of Trauma and Dissociation (ISSTD) expert-consensus guidelines recommend phase-oriented treatment with three phases: (1) safety, stabilization, and symptom reduction; (2) work with traumatic memories; (3) integration and rehabilitation.⁶
• Phase 1 emphasizes psychoeducation, affect regulation, grounding skills, safety planning, and treatment-frame stability before any trauma processing.⁶
• Phase 2 uses trauma-focused techniques — including trauma-focused cognitive behavioral therapy, EMDR, and modified prolonged exposure — pacing trauma exposure carefully to avoid destabilization.^6,12
• Phase 3 focuses on consolidating gains, building functional capacities, and integrating self-states or autobiographical memory.⁶
• For DPDR, cognitive behavioral therapy targeting catastrophic appraisals of dissociative symptoms has shown modest benefit in small trials.⁴
• Limited evidence supports EMDR for dissociative amnesia and dissociative subtype of PTSD when appropriately staged.^6,12

Neuromodulation

• Repetitive transcranial magnetic stimulation targeting the right temporoparietal junction has shown preliminary benefit for DPDR in small open trials and one sham-controlled study, with low-certainty evidence.⁴
• Electroconvulsive therapy has no established role in primary dissociative disorders and may worsen dissociation; it remains an option for severe comorbid depression refractory to other treatments.^6,11

Adjunctive

• Skills-based group interventions (e.g., Trauma Recovery and Empowerment Model, TREM; Seeking Safety) can support phase 1 stabilization.⁶
• Address comorbid substance use, sleep disturbance, and self-injury actively; untreated comorbidity is among the strongest predictors of poor outcome.^6,11
• Coordinate with primary care for somatic symptoms and ensure consistent treatment team communication to limit splitting and crisis escalation.⁶

The harms picture in dissociative disorders is dominated by iatrogenic risks of misdiagnosis and inappropriate treatment, harms of untreated comorbidity, and the limitations of an evidence base built largely on case series and small open trials. The clinician should weigh these explicitly when planning care.

Harms of treatment

• Premature or unsupported trauma processing can precipitate destabilization, increased dissociation, self-injury, and suicidal crisis.⁶
• Suggestive or hypnotic interview techniques can produce confabulated memories with significant personal, family, and forensic consequences.^6,9
• Benzodiazepines and anticholinergic burden can worsen dissociation, sedation, and cognitive impairment.^6,11
• Misdiagnosis as schizophrenia leads to long-term antipsychotic exposure with metabolic and movement-related adverse effects without targeting the primary pathology.^2,6

Harms of under-treatment

• Untreated DID carries lifetime suicide-attempt rates above 70% in clinical samples; recurrent self-injury, hospitalizations, and occupational disability are common.^2,6
• Comorbid substance use, PTSD, and depression progress without targeted treatment when dissociation dominates the clinical picture.^2,6

Limitations of the evidence base

• No large, multisite randomized trials exist for DID; the strongest treatment-outcome data come from the Treatment of Patients with Dissociative Disorders (TOP DD) prospective naturalistic studies.⁶
• Trials in DPDR are small, short, and heterogeneous in outcome measures, limiting confidence in any specific pharmacologic recommendation.⁴
• Publication bias toward positive case series and the absence of placebo-controlled trials in DID inflate apparent treatment effects.^6,9
• Cultural variability in dissociative phenomenology limits generalizability across populations; most published data derive from Western specialty-clinic samples.^5-6

Developmental stage, reproductive context, and culture shape both the presentation of dissociation and the safety of treatment choices. The general principles — phase-oriented psychotherapy and conservative pharmacotherapy targeting comorbidity — apply across populations, with adjustments for age and context.

Pediatric and adolescent

• Childhood dissociation is most often expressed as trance-like states, vivid imaginary companions beyond developmentally appropriate ages, marked behavioral inconsistency, and amnesia for misbehavior.^5-6
• The Child Dissociative Checklist (CDC) and Adolescent Dissociative Experiences Scale (A-DES) are validated screens.^6,11
• Treatment is family-inclusive, trauma-informed, and developmentally adapted; antipsychotics and benzodiazepines should be minimized.^6,11
• Mandatory child-protection reporting obligations apply when ongoing abuse is disclosed or suspected.⁶

Geriatric

• New-onset dissociative symptoms in older adults require thorough medical and neurologic workup before primary dissociative attribution.^3-4
• Pre-existing dissociative disorders may present with cognitive complaints that mimic neurocognitive disorder; serial cognitive testing helps differentiate.^3,6

Perinatal

• Pregnancy and postpartum can destabilize previously compensated dissociative pathology, particularly when the patient has a history of childhood sexual abuse.⁶
• SSRI selection follows standard perinatal psychiatric considerations; avoid abrupt discontinuation of stabilizing medications without explicit risk-benefit discussion.^6,11

Comorbid medical and substance

• Coordinate with primary care for somatoform symptoms, functional neurologic disorder, and chronic pain, which frequently co-occur with DID.^2,6
• Address substance use disorders concurrently; sequential treatment delays recovery and inflates relapse risk.^6,11

Cultural considerations

• Cultural concepts of distress — including dissociative trance phenomena recognized in many non-Western societies — must be distinguished from pathologic dissociation using context, distress, and impairment.^1,5
• ICD-11 explicitly accommodates culturally normative trance and possession phenomena outside the disorder category.¹⁰

Outcomes in dissociative disorders are heterogeneous and depend more on treatment access, comorbidity management, and safety than on any specific pharmacologic decision. With sustained phase-oriented care, meaningful functional gains are achievable, but the timeline is measured in years rather than months.

Natural history

• Untreated DID typically follows a chronic, fluctuating course with multiple comorbidities and recurrent crises; spontaneous remission is uncommon.^2,6
• Dissociative amnesia after acute trauma often resolves substantially within weeks to months when the precipitating stressor is contained; generalized and continuous forms have poorer prognosis.^3,5
• DPDR typically follows a chronic, fluctuating course; about one-third of patients show meaningful improvement over years, one-third remain stable, and the remainder progress.⁴

Treatment response

• TOP DD prospective data report significant reductions in dissociation, PTSD symptoms, depression, self-injury, and hospitalization, alongside improved function, over 30 months of phase-oriented therapy.⁶
• Predictors of better outcome include treatment-frame stability, lower baseline self-injury, fewer comorbidities, and absence of ongoing trauma exposure.⁶
• Predictors of poorer outcome include severe personality pathology, chronic substance use, ongoing victimization, and severe medical comorbidity.⁶

Suicide and mortality

• Lifetime suicide-attempt rates above 70% in clinical DID cohorts make suicide risk assessment a recurring rather than one-time task.^2,6
• All-cause and suicide-specific mortality data for DID are limited but suggest elevation comparable to severe mood and trauma disorders.^2,6

Dissociative crises commonly present to the emergency department as self-injury, suicidal behavior, fugue, agitation, or apparent psychosis. The acute task is to stabilize safety, contain regression, and avoid iatrogenic harm, not to make a final dissociative diagnosis in the emergency setting.

Hospitalization criteria

• Active suicidal ideation with plan or intent, recent serious self-injury, acute fugue with inability to ensure safety, or acute decompensation with loss of reality testing warrant inpatient admission.^6,11
• Brief, focused admissions oriented to safety and stabilization are preferable to prolonged hospitalizations, which can reinforce regression and dependency.⁶

Acute management

• Reduce sensory load, provide grounding (orienting to time, place, surroundings, body), and use clear, simple language; engage the part of the patient most able to communicate.⁶
• Avoid restraints and seclusion when feasible; both can re-enact prior trauma and worsen dissociation.⁶
• For severe agitation, use the lowest effective dose of a sedating medication, prefer oral over parenteral, and reassess frequently; benzodiazepines can worsen dissociation and should be limited.^6,11
• Treat any reversible medical contributor — hypoglycemia, intoxication, head injury — before attributing acute presentation to a primary dissociative disorder.^3-4

Few areas of contemporary psychiatry remain as contested as dissociative identity disorder. The disagreements are substantive, concerning etiology, prevalence, treatment, and even the validity of the diagnosis, and they have direct implications for how clinicians weigh patient reports and design care.

Trauma vs sociocognitive models

• Proponents of the trauma model cite imaging, treatment-response, prospective developmental, and cross-cultural data supporting DID as a chronic outcome of early interpersonal trauma.^5-7
• Proponents of the sociocognitive (fantasy) model argue that DID is largely iatrogenic or culturally shaped, citing rising prevalence after media exposure and the role of suggestive techniques.⁹
• Most contemporary clinicians and researchers accept the trauma model while acknowledging that suggestive interviewing and cultural factors can shape presentation and that careful, non-leading assessment is essential.^6,9

Diagnostic validity and reliability

• Inter-rater reliability of DID using the SCID-D is moderate to good in research settings; reliability in routine clinical practice is lower and depends on clinician training.^6,11
• Critics argue that DID symptoms can be produced by suggestion in non-clinical samples, while defenders argue that core features (developmental amnesia, identity alteration with functional consequences, neurobiological correlates) cannot be readily simulated.^6,9

Forensic and legal complexities

• Recovered-memory cases in the 1990s produced lasting forensic skepticism about trauma-recall claims arising during therapy.^6,9
• Current clinical-forensic standards require careful documentation, avoidance of suggestive techniques, and clear distinction between clinical and forensic interview contexts.^6,9
• Diminished-responsibility and competence-to-stand-trial questions in DID are handled inconsistently across jurisdictions.⁶

Treatment evidence gaps

• The absence of large RCTs in DID leaves the field reliant on naturalistic prospective data and expert consensus, which are subject to selection and observer bias.⁶
• Pharmacotherapy trials in DPDR are small and have produced inconsistent results for lamotrigine, naltrexone, and other agents.⁴
• Cultural variability in dissociative phenomenology limits the generalizability of treatment data derived from Western specialty clinics.^5-6

• DSM-5-TR groups dissociative disorders as dissociative identity disorder, dissociative amnesia (with or without dissociative fugue), depersonalization/derealization disorder, and other specified / unspecified dissociative disorder.¹
• DID requires two or more distinct personality states with recurrent gaps in recall inconsistent with ordinary forgetting and clinically significant distress or impairment.¹
• Dissociative fugue is now coded as a specifier of dissociative amnesia, not a separate disorder.¹
• Reality testing is preserved in depersonalization/derealization disorder, distinguishing it from psychosis.^1,4
• Childhood maltreatment, particularly chronic physical and sexual abuse before age 9, is the most replicated risk factor for chronic dissociative disorders.^2,5-6
• Dissociative voices in DID are typically internal and ego-syntonic, contrasting with the external, ego-dystonic voices of schizophrenia.^2,6
• The DES-II is a 28-item self-report screen; the SCID-D is the reference-standard semi-structured diagnostic interview for dissociative disorders.^6,11
• Phase-oriented psychotherapy with three phases — safety/stabilization, trauma processing, integration — is the consensus framework for DID care.⁶
• No medication is FDA-approved for any dissociative disorder; pharmacotherapy targets comorbid depression, anxiety, and PTSD.^6,11
• Benzodiazepines and high-potency anticholinergic medications can worsen dissociation and impede trauma-focused psychotherapy.^6,11
• Temporal lobe epilepsy, transient global amnesia, autoimmune encephalitis, and substance intoxication are core medical-neurologic differentials for new-onset dissociative symptoms.^3-4
• Sodium amytal interviews and hypnotically refreshed memory are not recommended for diagnostic assessment because of confabulation risk.^6,9
• ICD-11 introduces partial dissociative identity disorder and separates dissociative neurologic symptom disorder; trance and possession trance disorders have explicit cultural-context criteria.¹⁰
• Lifetime suicide-attempt rates exceed 70% in clinical DID cohorts, making recurring suicide-risk assessment essential.^2,6

No external funding. No conflicts of interest declared. Peer-review status: pending.